The many facets of hyperhomocysteinemia: studies from the Framingham cohorts

Homocysteine is a sulfur amino acid whose metabolism stands at the intersection of 2 pathways: remethylation, which requires folic acid and B-12 coenzymes, and transsulfuration, which requires pyridoxal-5'-phosphate, the B-6 coenzyme. Data from several studies suggest that mild elevations of ho...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:The Journal of nutrition Ročník 136; číslo 6 Suppl; s. 1726S
Hlavný autor: Selhub, Jacob
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 01.06.2006
Predmet:
Aged
Aged, 80 and over
Alzheimer Disease - epidemiology
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - mortality
Carotid Stenosis - etiology
Cohort Studies
Dementia - epidemiology
Diet
Female
Folic Acid - administration & dosage
Folic Acid - blood
Fractures, Bone
Heart Failure - epidemiology
Homocysteine - blood
Humans
Hyperhomocysteinemia - complications
Male
Massachusetts
Middle Aged
Risk Factors
Stroke - epidemiology
Vascular Diseases - etiology
Vitamin B 12 - administration & dosage
Vitamin B 12 - blood
Vitamin B 6 - administration & dosage
Vitamin B 6 - blood
Massachusetts
ISSN:0022-3166
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Homocysteine is a sulfur amino acid whose metabolism stands at the intersection of 2 pathways: remethylation, which requires folic acid and B-12 coenzymes, and transsulfuration, which requires pyridoxal-5'-phosphate, the B-6 coenzyme. Data from several studies suggest that mild elevations of homocysteine in plasma are a risk factor for occlusive vascular disease. In the Framingham studies we have shown that plasma total homocysteine concentration is inversely related to the intake and plasma levels of folate and vitamin B-6 as well as vitamin B-12 plasma levels. Almost two-thirds of the prevalence of high homocysteine is attributable to low vitamin status or intake. Elevated homocysteine concentrations in plasma are a risk factor for prevalence of extracranial carotid artery stenosis of at least 25% in both men and women. Prospectively elevated plasma homocysteine is associated with increased total and CVD mortality, increased incidence of stroke, increased incidence of dementia and Alzheimer's disease, increased incidence of bone fracture, and higher prevalence of chronic heart failure. This multitude of relationships between elevated plasma total homocysteine and diseases that afflict the elderly point to the existence of a common denominator that may be responsible for these diseases. Whether this denominator is homocysteine itself or whether homocysteine is merely a marker remains to be determined.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0022-3166
DOI:10.1093/jn/136.6.1726S